Literature DB >> 31571272

New Drugs, New Ideas: Payment Policy Innovations for High-Cost Pharmaceuticals.

Brian J Miller, Gail Wilensky.   

Abstract

Year:  2019        PMID： 31571272      PMCID： PMC6904288          DOI： 10.1111/1468-0009.12422

Source DB:  PubMed          Journal:  Milbank Q        ISSN： 0887-378X            Impact factor:   4.911


× No keyword cloud information.
  5 in total

1.  An Overview of Cancer Drugs Approved by the US Food and Drug Administration Based on the Surrogate End Point of Response Rate.

Authors:  Emerson Y Chen; Vikram Raghunathan; Vinay Prasad
Journal:  JAMA Intern Med       Date:  2019-07-01       Impact factor: 21.873

2.  Estimation of Study Time Reduction Using Surrogate End Points Rather Than Overall Survival in Oncology Clinical Trials.

Authors:  Emerson Y Chen; Sunil K Joshi; Audrey Tran; Vinay Prasad
Journal:  JAMA Intern Med       Date:  2019-05-01       Impact factor: 21.873

Review 3.  A 25-Year Experience of US Food and Drug Administration Accelerated Approval of Malignant Hematology and Oncology Drugs and Biologics: A Review.

Authors:  Julia A Beaver; Lynn J Howie; Lorraine Pelosof; Tamy Kim; Jinzhong Liu; Kirsten B Goldberg; Rajeshwari Sridhara; Gideon M Blumenthal; Ann T Farrell; Patricia Keegan; Richard Pazdur; Paul G Kluetz
Journal:  JAMA Oncol       Date:  2018-06-01       Impact factor: 31.777

Review 4.  Assessment of the Clinical Benefit of Cancer Drugs Receiving Accelerated Approval.

Authors:  Bishal Gyawali; Spencer Phillips Hey; Aaron S Kesselheim
Journal:  JAMA Intern Med       Date:  2019-07-01       Impact factor: 21.873

5.  Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration.

Authors:  Huseyin Naci; Katelyn R Smalley; Aaron S Kesselheim
Journal:  JAMA       Date:  2017-08-15       Impact factor: 56.272
  5 in total
  1 in total

Review 1.  A systematic review of pharmaceutical price mark-up practice and its implementation.

Authors:  Kah Seng Lee; Yaman Walid Kassab; Nur Akmar Taha; Zainol Akbar Zainal
Journal:  Explor Res Clin Soc Pharm       Date:  2021-05-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.